Listed

Benitec Biopharma Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 12, 2021 and accepted by EDGAR at May 12, 2021, 17:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$1.0kus-gaap:Revenues
Revenue9 months2020-07-01 to 2021-03-31$57.0kus-gaap:Revenues
Research and development3 months2021-01-01 to 2021-03-31$2.8mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2020-07-01 to 2021-03-31$4.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-01-01 to 2021-03-31−$3.8mus-gaap:OperatingIncomeLoss
Operating income9 months2020-07-01 to 2021-03-31−$9.7mus-gaap:OperatingIncomeLoss
Net income3 months2021-01-01 to 2021-03-31−$3.9mus-gaap:NetIncomeLoss
Net income9 months2020-07-01 to 2021-03-31−$9.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.82us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2020-07-01 to 2021-03-31−$2.93us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2020-07-01 to 2021-03-31−$7.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-07-01 to 2021-03-31$362.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$12.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$12.4mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$13.4mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$2.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$2.5mus-gaap:Liabilities
Shareholders' equityAt period end2021-03-31$10.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-21-159276. Last ingested by Listed: Nov 14, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.